Is there a difference in the risk of transmission?
Coronavirus
disease 2019 (COVID-19) is a syndrome induced by infection with the
coronavirus that causes severe acute respiratory syndrome (SARS-CoV-2) and is
linked to epidemics in crowded settings. Despite its rapid global spread,
nonpharmaceutical measures including as physical separation and prompt
isolation of symptomatic patients have been reported to be successful in
preventing transmission in both institutions and the general public. COVID-19
and influenza (flu) are both infectious respiratory infections caused by
distinct viruses. COVID-19 is caused by infection with a coronavirus that was
first identified in 2019, while flu is caused by infection with a virus that
was first identified in 1918.
Time spent with
infected individuals appears to be a primary driver of COVID-19 transmission,
according to reports describing risk factors for COVID-19 dissemination. More
severe disease in the source patient was also recognised as a risk factor for
disease diffusion in a research investigating secondary infection in China.
Many of these investigations took place in the absence of or in the midst of
evolving nonpharmaceutical interventions, making it difficult to compare the
contributions of public health initiatives to patients in disease
spread.
When a person comes
into close contact (within 1 m) with someone who has respiratory symptoms
(e.g., coughing or sneezing) and is exposed to potentially infective
respiratory droplets on his or her mucosae (mouth and nose) or conjunctiva, droplet
transmission occurs (eyes). Fomites in the sick person's immediate
environment can also transmit the disease. 8 As a result, the COVID-19 virus
can be spread through direct contact with infected people as well as by
indirect contact with nearby surfaces or products used on the infected person
(e.g., stethoscope or thermometer).
Comments
Post a Comment